INNOVOTEX Appoints Dr. Krystle Karoscik as CEO to Advance Macrocycle Drug Conjugate Platform into the Clinic
AUSTIN, TX, UNITED STATES, May 14, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a pharmaceutical company advancing a new class of tumor-selective oncology therapeutics known as Macrocycle Drug Conjugates (MDCs), today announced the appointment of Dr. …